ERIS / NSE / Biotechnology & Drugs
Eris Lifesciences
1Y Price Trend
Key Information
Recommendations
RatingStrong Buy
Target High1,887.65
Target Low1,237.9
Target Mean1.6
Target Median75
Risk Metrics
Overall RiskBalanced risk
Board Risk32.57
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
ERIS Lifesciences Ltd Valuation Shifts Signal Changing Market Sentiment Markets Mojo
Eris Lifesciences - Ipca Laboratories among 5 stocks showing bullish RSI upswing The Economic Times
ERIS Lifesciences Ltd is Rated Hold Markets Mojo
Eris Lifesciences fined ₹4.24 lakh for board composition lapse scanx.trade
Eris promoters confirm no encumbrance on 53.92% stake scanx.trade
Eris Lifesciences posts analyst call transcript for Q4FY26 scanx.trade
ERIS Lifesciences Ltd Valuation Shifts Signal Renewed Price Attractiveness Markets Mojo
Eris Lifesciences to meet Franklin Templeton on May 29 scanx.trade
Stock FAQs
What is the symbol and ISIN of Eris Lifesciences?
Eris Lifesciences has the symbol ERIS and ISIN - INE406M01024.
What is the current price of Eris Lifesciences?
Eris Lifesciences is currently trading at INR 1,436.70.
What are the year high and year low of Eris Lifesciences?
Eris Lifesciences has a year high of INR 1,887.65 and a year low of INR 1,237.90.
What is the market capitalization of Eris Lifesciences?
Eris Lifesciences has a market capitalization of INR 19,910.53 crore.
What is the P/E ratio of Eris Lifesciences?
Eris Lifesciences has a P/E ratio of 28.57.
What is the dividend yield of Eris Lifesciences?
Eris Lifesciences has a dividend yield of 0.50%.
How is the financial performance of Eris Lifesciences based on revenue, net income, and EPS?
Eris Lifesciences has revenue of INR 31,294.20 crore, net income of INR 6,195.20 crore, and EPS of INR 46.28.
What is the book value of Eris Lifesciences?
Eris Lifesciences has a book value of INR -41.61.
What is the debt-to-equity ratio of Eris Lifesciences?
Eris Lifesciences has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Eris Lifesciences?
Eris Lifesciences has a price-to-book ratio of -34.53 and a price-to-sales ratio of 0.64.
© SharekeyX | Rusaka Technologies 2024-2026